Janus head: The dual role of HLA-G in CNS immunity

Cellular and Molecular Life Sciences

Volumn 68, Issue 3, 2011, Pages 407-416

  Huang, Yu Hwa ^a   Airas, Laura ^b   Schwab, Nicholas ^a   Wiendl, Heinz ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Blood brain barrier; Central nervous system; Human lymphocyte antigen G; Immune surveillance; Immune tolerance; Multiple sclerosis

Indexed keywords

ALPHA FETOPROTEIN; CD200 ANTIGEN; FAS LIGAND; HLA G ANTIGEN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR T BET;

ADAPTIVE IMMUNITY; ANTIGEN DETECTION; ANTIGEN FUNCTION; ASTROCYTE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN TUMOR; CARCINOGENESIS; CELL COMMUNICATION; CELL INTERACTION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; DISEASE ACTIVITY; DISEASE COURSE; HOMEOSTASIS; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; MALIGNANT TRANSFORMATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; OLIGODENDROGLIA; OVERALL SURVIVAL; PREGNANCY; PROTEIN BLOOD LEVEL; RECURRENCE RISK; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE;

EID: 79951555727     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0582-5     Document Type: Review

References (90)

1. S Kovats EK Main C Librach M Stubblebine SJ Fisher R DeMars 1990 A class I antigen, HLA-G, expressed in human trophoblasts Science 248 220 223 1:CAS:528:DyaK3cXktVChuro%3D 10.1126/science.2326636 2326636 (Pubitemid 120031455)
2. P Le Bouteiller 1995 Regulation of the expression of HLA class I genes in human trophoblasts Pathol Biol (Paris) 43 628 635 1:STN:280: DyaK287ks1ygsg%3D%3D
3. R Apps L Gardner A Moffett 2008 A critical look at HLA-G Trends Immunol 29 313 321 1:CAS:528:DC%2BD1cXnvVGlsLc%3D 10.1016/j.it.2008.02.012 18538632
4. ED Carosella P Moreau J Le Maoult M Le Discorde J Dausset N Rouas-Freiss 2003 HLA-G molecules: from maternal-fetal tolerance to tissue acceptance Adv Immunol 81 199 252 1:CAS:528:DC%2BD2cXhvFaqsrk%3D 10.1016/S0065-2776(03)81006-4 14711057 (Pubitemid 38009044)
5. A Arnaiz-Villena J Martinez-Laso JI Serrano-Vela R Reguera J Moscoso 2007 HLA-G polymorphism and evolution Tissue Antigens 69 Suppl 1 156 159 1:CAS:528:DC%2BD2sXmt1Cnt7Y%3D 10.1111/j.1399-0039.2006.763-8.x 17445193 (Pubitemid 46625877)
6. M Onno T Guillaudeux L Amiot I Renard B Drenou B Hirel M Girr G Semana P Le Bouteiller R Fauchet 1994 The HLA-G gene is expressed at a low mRNA level in different human cells and tissues Hum Immunol 41 79 86 1:CAS:528: DyaK2MXhvVKhtrc%3D 10.1016/0198-8859(94)90089-2 7836069 (Pubitemid 24319055)
7. WF Hickey 2001 Basic principles of immunological surveillance of the normal central nervous system Glia 36 118 124 1:STN:280:DC%2BD3MrkvVylsA%3D%3D 10.1002/glia.1101 11596120 (Pubitemid 33055900)
8. B Becher I Bechmann M Greter 2006 Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain J Mol Med 84 532 543 1:CAS:528:DC%2BD28XmsFSmurw%3D 10.1007/s00109-006-0065-1 16773356 (Pubitemid 43992845)
9. F Zipp O Aktas 2006 The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases Trends Neurosci 29 518 527 1:CAS:528:DC%2BD28XptVGntLs%3D 10.1016/j.tins.2006.07.006 16879881 (Pubitemid 44291819)
10. M Ueno 2009 Mechanisms of the penetration of blood-borne substances into the brain Curr Neuropharmacol 7 142 149 1:CAS:528:DC%2BD1MXht1Cjur%2FE 10.2174/157015909788848901 19949573
11. WF Hickey 1991 Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation Brain Pathol 1 97 105 1:STN:280:DyaK2c7it12ntw%3D%3D 10.1111/j.1750-3639.1991.tb00646.x 1669702
12. WF Hickey BL Hsu H Kimura 1991 T lymphocyte entry into the central nervous system J Neurosci Res 28 254 260 1:STN:280:DyaK3M3jslOnug%3D%3D 10.1002/jnr.490280213 2033653
13. CS Raine B Cannella AM Duijvestijn AH Cross 1990 Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination Lab Invest 63 476 489 1:STN:280:DyaK3M%2FktVKqtQ%3D%3D 1700193 (Pubitemid 20368727)
14. JJ Campbell EP Bowman K Murphy KR Youngman MA Siani DA Thompson L Wu A Zlotnik EC Butcher 1998 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7 J Cell Biol 141 1053 1059 1:CAS:528:DyaK1cXjt1Kltbk%3D 10.1083/jcb.141.4.1053 9585422 (Pubitemid 28243971)
15. JE Simpson J Newcombe ML Cuzner MN Woodroofe 1998 Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions J Neuroimmunol 84 238 249 1:CAS:528:DyaK1cXitlSqs7Y%3D 10.1016/S0165-5728(97)00208-7 9628469 (Pubitemid 28248412)
16. CM McManus CF Brosnan JW Berman 1998 Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia J Immunol 160 1449 1455 1:CAS:528:DyaK1cXnsleisg%3D%3D 9570566 (Pubitemid 28093447)
17. Y Dong EN Benveniste 2001 Immune function of astrocytes Glia 36 180 190 1:STN:280:DC%2BD3MrkvVylug%3D%3D 10.1002/glia.1107 11596126 (Pubitemid 33055906)
18. D Vajtr O Benada J Kukacka R Prusa L Houstava P Toupalik R Kizek 2009 Correlation of ultrastructural changes of endothelial cells and astrocytes occurring during blood-brain barrier damage after traumatic brain injury with biochemical markers of BBB leakage and inflammatory response Physiol Res 58 263 268 1:CAS:528:DC%2BD1MXlslOisbY%3D 18380546
19. NP Hailer FL Heppner D Haas R Nitsch 1998 Astrocytic factors deactivate antigen-presenting cells that invade the central nervous system Brain Pathol 8 459 474 1:CAS:528:DyaK1cXksFCmtr8%3D 10.1111/j.1750-3639.1998.tb00168.x 9669697 (Pubitemid 28308845)
20. AU Neumann NP Lam H Dahari DR Gretch TE Wiley TJ Layden AS Perelson 1998 Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 103 107 1:CAS:528:DyaK1cXmsFOjsLc%3D 10.1126/science.282.5386.103 9756471 (Pubitemid 28471138)
21. M Kerschensteiner E Gallmeier L Behrens VV Leal T Misgeld WE Klinkert R Kolbeck E Hoppe RL Oropeza-Wekerle I Bartke C Stadelmann H Lassmann H Wekerle R Hohlfeld 1999 Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189 865 870 1:CAS:528: DyaK1MXhsF2ju7k%3D 10.1084/jem.189.5.865 10049950 (Pubitemid 29189691)
22. Y Liu I Teige B Birnir S Issazadeh-Navikas 2006 Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE Nat Med 12 518 525 1:CAS:528:DC%2BD28Xkt1Kju7g%3D 10.1038/nm1402 16633347
23. A Jurewicz WE Biddison JP Antel 1998 MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes J Immunol 160 3056 3059 1:CAS:528:DyaK1cXhvVWqsbk%3D 9510211 (Pubitemid 28136763)
24. S D'Souza K Alinauskas E McCrea C Goodyer JP Antel 1995 Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury J Neurosci 15 7293 7300 7472483
25. B Bonetti CS Raine 1997 Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis Ann Neurol 42 74 84 1:STN:280:DyaK2szmvFajsg%3D%3D 10.1002/ana.410420113 9225688 (Pubitemid 27304783)
26. K Akassoglou J Bauer G Kassiotis M Pasparakis H Lassmann G Kollias L Probert 1998 Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy Am J Pathol 153 801 813 1:CAS:528:DyaK1cXmtFKnu7s%3D 9736029 (Pubitemid 28419033)
27. DY Jung H Lee BY Jung J Ock MS Lee WH Lee K Suk 2005 TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker J Immunol 174 6467 6476 1:CAS:528: DC%2BD2MXjvV2mu7g%3D 15879150 (Pubitemid 40663842)
28. R Alarcon C Fuenzalida M Santibanez R von Bernhardi 2005 Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid J Biol Chem 280 30406 30415 1:CAS:528:DC%2BD2MXos1Cru7c%3D 10.1074/jbc.M414686200 15987691 (Pubitemid 41216224)
29. E Ulvestad K Williams C Vedeler J Antel H Nyland S Mork R Matre 1994 Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG J Neurol Sci 121 125 131 1:STN:280: DyaK2c3gvF2ktA%3D%3D 10.1016/0022-510X(94)90340-9 8158203 (Pubitemid 24044876)
30. H Wiendl U Feger M Mittelbronn C Jack B Schreiner C Stadelmann J Antel W Brueck R Meyermann A Bar-Or BC Kieseier M Weller 2005 Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity Brain 128 2689 2704 10.1093/brain/awh609 16123145 (Pubitemid 41552952)
31. E Fainardi R Rizzo L Melchiorri M Stignani M Castellazzi C Tamborino E Paolino MR Tola E Granieri OR Baricordi 2008 CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis Mult Scler 14 446 454 1:CAS:528:DC%2BD1cXosFGgsL8%3D 10.1177/1352458507085137 18208868 (Pubitemid 351943856)
32. E Fainardi R Rizzo L Melchiorri L Vaghi M Castellazzi A Marzola V Govoni E Paolino MR Tola E Granieri OR Baricordi 2003 Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings J Neuroimmunol 142 149 158 1:CAS:528:DC%2BD3sXnsVags7g%3D 10.1016/S0165-5728(03) 00266-2 14512174 (Pubitemid 38368598)
33. AL Zozulya H Wiendl 2008 The role of regulatory T cells in multiple sclerosis Nat Clin Pract Neurol 4 384 398 1:CAS:528:DC%2BD1cXotFemsr8%3D 10.1038/ncpneuro0832 18578001 (Pubitemid 352003290)
34. YH Huang AL Zozulya C Weidenfeller I Metz D Buck KV Toyka W Bruck H Wiendl 2009 Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis Ann Neurol 66 171 183 1:CAS:528:DC%2BD1MXht1ansrbL 10.1002/ana.21705 19705413
35. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups National Cancer Institute of Canada Clinical Trials Group 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 1:CAS:528:DC%2BD2MXit1Wksbk%3D 10.1056/NEJMoa043330 15758009 (Pubitemid 40349501)
36. P Nyberg T Salo R Kalluri 2008 Tumor microenvironment and angiogenesis Front Biosci 13 6537 6553 1:CAS:528:DC%2BD1cXnsVOitLw%3D 10.2741/3173 18508679
37. ED Carosella A Horuzsko 2007 HLA-G and cancer Semin Cancer Biol 17 411 412 10.1016/j.semcancer.2007.06.014 17698367 (Pubitemid 350052591)
38. JJ Sheu leM Shih 2007 Clinical and biological significance of HLA-G expression in ovarian cancer Semin Cancer Biol 17 436 443 1:CAS:528: DC%2BD2sXht12hsrzO 10.1016/j.semcancer.2007.06.012 17681474 (Pubitemid 350052589)
39. N Rouas-Freiss P Moreau S Ferrone ED Carosella 2005 HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 65 10139 10144 1:CAS:528:DC%2BD2MXht1WgurnN 10.1158/0008-5472.CAN-05-0097 16287995 (Pubitemid 41743699)
40. N Rouas-Freiss P Moreau C Menier ED Carosella 2003 HLA-G in cancer: a way to turn off the immune system Semin Cancer Biol 13 325 336 1:CAS:528: DC%2BD3sXptVCntro%3D 10.1016/S1044-579X(03)00023-3 14708712 (Pubitemid 38160931)
41. M Urosevic R Dummer 2003 HLA-G in skin cancer: a wolf in sheep's clothing? Hum Immunol 64 1073 1080 1:CAS:528:DC%2BD3sXos1Kgu7Y%3D 10.1016/j.humimm.2003.08.351 14602238 (Pubitemid 37413717)
42. M Urosevic A Trojan R Dummer 2002 HLA-G and its KIR ligands in cancer - another enigma yet to be solved? J Pathol 196 252 253 10.1002/path.1057 11857486 (Pubitemid 34189412)
43. H Wiendl M Mitsdoerffer M Weller 2003 Hide and seek in the brain: a role for HLA-G mediating immune privilege for glioma cells Semin Cancer Biol 13 343 351 1:CAS:528:DC%2BD3sXptVCntrY%3D 10.1016/S1044-579X(03)00025-7 14708714 (Pubitemid 38160933)
44. H Wiendl M Mitsdoerffer M Weller 2002 A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape J Immunol 168 4772 4780 1:CAS:528:DC%2BD38Xjt12jurg%3D 11971028 (Pubitemid 34441386)
45. F Morandi I Levreri P Bocca B Galleni L Raffaghello S Ferrone I Prigione V Pistoia 2007 Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release Cancer Res 67 6433 6441 1:CAS:528:DC%2BD2sXnsVyqtbo%3D 10.1158/0008-5472.CAN-06-4588 17616704 (Pubitemid 47037528)
46. M Lafon C Prehaud F Megret M Lafage G Mouillot M Roa P Moreau N Rouas-Freiss ED Carosella 2005 Modulation of HLA-G expression in human neural cells after neurotropic viral infections J Virol 79 15226 15237 1:CAS:528:DC%2BD28XhslOiug%3D%3D 10.1128/JVI.79.24.15226-15237.2005 16306594 (Pubitemid 43032305)
47. DA Hafler 2004 Multiple sclerosis J Clin Invest 113 788 794 1:CAS:528:DC%2BD2cXisVagtLw%3D 15067307 (Pubitemid 38544133)
48. L Steinman S Zamvil 2003 Transcriptional analysis of targets in multiple sclerosis Nat Rev Immunol 3 483 492 1:CAS:528:DC%2BD3sXktFOhtbw%3D 10.1038/nri1108 12776208 (Pubitemid 37339188)
49. JH Noseworthy C Lucchinetti M Rodriguez BG Weinshenker 2000 Multiple sclerosis N Engl J Med 343 938 952 1:STN:280:DC%2BD3cvlvF2quw%3D%3D 10.1056/NEJM200009283431307 11006371
50. DA Hafler JM Slavik DE Anderson KC O'Connor P De Jager C Baecher-Allan 2005 Multiple sclerosis Immunol Rev 204 208 231 1:CAS:528:DC%2BD2MXkslGns7c%3D 10.1111/j.0105-2896.2005.00240.x 15790361 (Pubitemid 40460504)
51. E Gonzalez-Rey A Chorny M Delgado 2007 Regulation of immune tolerance by anti-inflammatory neuropeptides Nat Rev Immunol 7 52 63 1:CAS:528: DC%2BD28XhtlCht7fK 10.1038/nri1984 17186031 (Pubitemid 46020827)
52. R Hohlfeld M Kerschensteiner E Meinl 2007 Dual role of inflammation in CNS disease Neurology 68 S58 S63 10.1212/01.wnl.0000275234.43506.9b 17548571 discussion S91-S96 (Pubitemid 46848613)
53. SL Kalled 2005 The role of BAFF in immune function and implications for autoimmunity Immunol Rev 204 43 54 1:CAS:528:DC%2BD2MXkslGnsrk%3D 10.1111/j.0105-2896.2005.00219.x 15790349 (Pubitemid 40460492)
54. E Meinl M Krumbholz R Hohlfeld 2006 B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation Ann Neurol 59 880 892 1:CAS:528:DC%2BD28XmslGgtL4%3D 10.1002/ana.20890 16718690 (Pubitemid 43830920)
55. M Kerschensteiner C Stadelmann G Dechant H Wekerle R Hohlfeld 2003 Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases Ann Neurol 53 292 304 1:CAS:528:DC%2BD3sXit1yntL0%3D 10.1002/ana.10446 12601697 (Pubitemid 36258633)
56. JA Aarli SJ Mork E Myrseth JL Larsen 1989 Glioblastoma associated with multiple sclerosis: coincidence or induction? Eur Neurol 29 312 316 1:STN:280:DyaK3c7gvVSntQ%3D%3D 10.1159/000116437 2691257 (Pubitemid 20015213)
57. OA Khan SC Bauserman MI Rothman EF Aldrich HS Panitch 1997 Concurrence of multiple sclerosis and brain tumor: clinical considerations Neurology 48 1330 1333 1:STN:280:DyaK2s3pslygtw%3D%3D 9153467 (Pubitemid 27240558)
58. D Paydarfar SM de la Monte 1997 Case records of the Massachusetts General Hospital weekly clinicopathological exercises: Case 12-1997: a 50-year-old woman with multiple sclerosis and an enlarging frontal-lobe mass N Engl J Med 336 1163 1171 1:STN:280:DyaK2s3jvVOmuw%3D%3D 10.1056/NEJM199704173361608 9099662 (Pubitemid 27374700)
59. S Shuangshoti GM Hjardermaal Y Ahmad JL Arden MM Herman 2003 Concurrence of multiple sclerosis and intracranial glioma: report of a case and review of the literature Clin Neuropathol 22 304 308 1:STN:280:DC%2BD3srptV2iuw%3D%3D 14672509 (Pubitemid 37541370)
60. G Frisullo AK Patanella V Nociti A Cianfoni R Iorio A Bianco A Marti PA Tonali AP Batocchi 2009 Glioblastoma in multiple sclerosis: a case report J Neurooncol 94 141 144 10.1007/s11060-009-9804-9 19214706
61. CM Warner M Comiskey PR Clisham CA Brenner 2004 Soluble HLA-G (sHLA-G) a predictor of IVF outcome? J Assist Reprod Genet 21 315 316 10.1023/B:JARG. 0000045469.08910.1e 15587143 (Pubitemid 39422806)
62. I Noci B Fuzzi R Rizzo L Melchiorri L Criscuoli S Dabizzi R Biagiotti S Pellegrini A Menicucci OR Baricordi 2005 Embryonic soluble HLA-G as a marker of developmental potential in embryos Hum Reprod 20 138 146 1:CAS:528: DC%2BD2MXisVSgsg%3D%3D 10.1093/humrep/deh572 15498780
63. ED Carosella P Moreau J Lemaoult N Rouas-Freiss 2008 HLA-G: from biology to clinical benefits Trends Immunol 29 125 132 1:CAS:528:DC%2BD1cXivVeis7Y%3D 10.1016/j.it.2007.11.005 18249584
64. H Wiendl 2007 HLA-G in the nervous system Hum Immunol 68 286 293 1:CAS:528:DC%2BD2sXjslShsrk%3D 10.1016/j.humimm.2006.10.021 17400065 (Pubitemid 46497519)
65. I Parolini C Federici C Raggi L Lugini S Palleschi A De Milito C Coscia E Iessi M Logozzi A Molinari M Colone M Tatti M Sargiacomo S Fais 2009 Microenvironmental pH is a key factor for exosome traffic in tumor cells J Biol Chem 284 34211 34222 1:CAS:528:DC%2BD1MXhsVymu7fN 10.1074/jbc.M109.041152 19801663
66. JS Schorey S Bhatnagar 2008 Exosome function: from tumor immunology to pathogen biology Traffic 9 871 881 1:CAS:528:DC%2BD1cXntlamsLk%3D 10.1111/j.1600-0854.2008.00734.x 18331451 (Pubitemid 351639493)
67. H Valadi K Ekstrom A Bossios M Sjostrand JJ Lee JO Lotvall 2007 Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 654 659 1:CAS:528:DC%2BD2sXmtVSmtb8%3D 10.1038/ncb1596 17486113 (Pubitemid 47214727)
68. J Ratajczak K Miekus M Kucia J Zhang R Reca P Dvorak MZ Ratajczak 2006 Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery Leukemia 20 847 856 1:CAS:528:DC%2BD28XjslOhsbs%3D 10.1038/sj.leu.2404132 16453000
69. J Skog T Würdinger S van Rijn DH Meijer L Gainche M Sena-Esteves WT Curry Jr BS Carter AM Krichevsky XO Breakefield 2008 Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 1470 1476 1:CAS:528:DC%2BD1cXhsVentbfI 10.1038/ncb1800 19011622
70. B Riteau F Faure C Menier S Viel ED Carosella S Amigorena N Rouas-Freiss 2003 Exosomes bearing HLA-G are released by melanoma cells Hum Immunol 64 1064 1072 1:CAS:528:DC%2BD3sXos1Kgu7k%3D 10.1016/j.humimm.2003.08.344 14602237 (Pubitemid 37413716)
71. AT Borchers SM Naguwa CL Keen ME Gershwin 2010 The implications of autoimmunity and pregnancy J Autoimmun 34 3 J287 J299 1:CAS:528: DC%2BC3cXjtVCksLo%3D 10.1016/j.jaut.2009.11.015 20031371
72. C Confavreux M Hutchinson MM Hours P Cortinovis-Tourniaire T Moreau 1998 Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group N Engl J Med 339 285 291 1:STN:280:DyaK1czjsF2ksg%3D%3D 10.1056/NEJM199807303390501 9682040 (Pubitemid 28366416)
73. M Saraste S Vaisanen A Alanen L Airas 2007 Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy Gend Med 4 45 55 10.1016/S1550-8579(07)80008-8 17584627
74. T Paavilainen T Kurki R Parkkola M Farkkila O Salonen P Dastidar I Elovaara L Airas 2007 Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis Eur J Neurol 14 1216 1221 1:STN:280:DC%2BD2snjtV2rsA%3D%3D 10.1111/j.1468-1331.2007.01927.x 17727663 (Pubitemid 47621941)
75. O Thellin E Heinen 2003 Pregnancy and the immune system: between tolerance and rejection Toxicology 185 179 184 1:CAS:528:DC%2BD3sXhtVCntLk%3D 10.1016/S0300-483X(02)00607-8 12581692 (Pubitemid 36173734)
76. P Luppi 2003 How immune mechanisms are affected by pregnancy Vaccine 21 3352 3357 1:CAS:528:DC%2BD3sXlt1eisL4%3D 10.1016/S0264-410X(03)00331-1 12850338 (Pubitemid 36792085)
77. JS Hunt MG Petroff RH McIntire C Ober 2005 HLA-G and immune tolerance in pregnancy FASEB J 19 681 693 1:CAS:528:DC%2BD2MXktVKmu78%3D 10.1096/fj.04- 2078rev 15857883 (Pubitemid 40617373)
78. L Airas M Saraste S Rinta I Elovaara YH Huang H Wiendl 2008 Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells Clin Exp Immunol 151 235 243 1:STN:280:DC%2BD1c%2Fjs1SqtA%3D%3D 10.1111/j.1365-2249.2007.03555.x 18062798
79. JH Gilmore LF Jarskog 1997 Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia Schizophr Res 24 365 367 1:STN:280:DyaK2s3otVansA%3D%3D 10.1016/S0920-9964(96)00123-5 9134598
80. TG Wegmann H Lin L Guilbert TR Mosmann 1993 Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14 353 356 1:CAS:528:DyaK3sXlsFOksL0%3D 10.1016/0167-5699(93)90235-D 8363725 (Pubitemid 23198169)
81. M Saraste J Ryynanen A Alanen J Multanen M Farkkila R Kaaja L Airas 2006 Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy J Neurol Neurosurg Psychiatry 77 1195 1196 1:STN:280: DC%2BD28rlsVOnsQ%3D%3D 10.1136/jnnp.2005.085126 16574729 (Pubitemid 44453259)
82. S Kim SM Liva MA Dalal MA Verity RR Voskuhl 1999 Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis Neurology 52 1230 1238 1:CAS:528:DyaK1MXivVyqtL8%3D 10214749 (Pubitemid 29177927)
83. MJ Polanczyk C Hopke J Huan AA Vandenbark H Offner 2005 Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice J Neuroimmunol 170 85 92 1:CAS:528:DC%2BD2MXhtlSitbvE 10.1016/j.jneuroim.2005.08. 023 16253347 (Pubitemid 41740909)
84. L Airas T Nikula YH Huang R Lahesmaa H Wiendl 2007 Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G J Neuroimmunol 187 205 211 1:CAS:528:DC%2BD2sXnsFKmuro%3D 10.1016/j.jneuroim.2007. 05.008 17561269 (Pubitemid 47008932)
85. DA Clark 2005 Tolerance signaling molecules Chem Immunol Allergy 89 36 48 1:CAS:528:DC%2BD2MXht1eiu7nO 10.1159/000087911 16129951 (Pubitemid 43154883)
86. BF Bebo Jr GS Dveksler 2005 Evidence that pregnancy specific glycoproteins regulate T cell function and inflammatory autoimmune disease during pregnancy Curr Drug Targets Inflamm Allergy 4 231 237 1:CAS:528:DC%2BD2MXlsFelsbg%3D 10.2174/1568010053586255 15853745 (Pubitemid 40873105)
87. M Irony-Tur-Sinai N Grigoriadis A Lourbopoulos F Pinto-Maaravi O Abramsky T Brenner 2006 Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein Exp Neurol 198 136 144 1:CAS:528:DC%2BD28Xhs1Sgu70%3D 10.1016/j.expneurol.2005.11.012 16423348 (Pubitemid 43243752)
88. U Feger E Tolosa YH Huang A Waschbisch T Biedermann A Melms H Wiendl 2007 HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation Blood 110 568 577 1:CAS:528:DC%2BD2sXot1emtrw%3D 10.1182/blood-2006-11-057125 17371944 (Pubitemid 47105395)
89. YH Huang AL Zozulya C Weidenfeller N Schwab H Wiendl 2009 T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible J Leukoc Biol 86 273 281 1:CAS:528: DC%2BD1MXps1emu70%3D 10.1189/jlb.1008649 19401389
90. HL Weiner DJ Selkoe 2002 Inflammation and therapeutic vaccination in CNS diseases Nature 420 879 884 1:CAS:528:DC%2BD38XpsFygtb0%3D 10.1038/nature01325 12490962 (Pubitemid 36019642)